Parkinson's Disease Tulip

Reply
 
Thread Tools Display Modes
Old 10-05-2007, 09:28 AM #1
olsen's Avatar
olsen olsen is offline
Senior Member
 
Join Date: Aug 2006
Posts: 1,854
10 yr Member
olsen olsen is offline
Senior Member
olsen's Avatar
 
Join Date: Aug 2006
Posts: 1,854
10 yr Member
Default Dopamine transporter relation to dopamine turnover in Parkinson's disease

(related links following abstract are also very interesting.)

Ann Neurol. 2007 Sep 20; [Epub ahead of print] Links
Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ.
University of British Columbia, Vancouver, British Columbia, Canada.

OBJECTIVE: To investigate the role of the dopamine transporter (DAT) in the regulation of synaptic dopamine (DA) levels in Parkinson's disease and its role in the preservation of DA in presynaptic terminals. METHODS: Ten Parkinson's disease patients (age, 62.9 +/- 9.5 years; Unified Parkinson's Disease Rating Scale motor score in "off" state, 28.5 +/- 8.2) underwent positron emission tomography with (11)C-methylphenidate (MP, a DAT marker), (11)C-dihydrotetrabenazine (a vesicular monoamine transporter 2 marker), and (18)F-fluorodopa, leading to the determination of the MP and (11)C-dihydrotetrabenazine binding potentials (BPs) and the effective distribution volume for (18)F-fluorodopa, the inverse of DA turnover. Seven patients also underwent positron emission tomography with (11)C-raclopride before and 1 hour after levodopa administration to estimate levodopa-induced changes in synaptic DA concentration. RESULTS: We found a significant positive correlation between effective distribution volume and BP(MP) (r = 0.93; p < 0.001) and a significant negative correlation between changes in synaptic DA concentration and BP(MP) (r = -0.93; p = 0.04), independent of disease severity and duration. INTERPRETATION: These data show that in Parkinson's disease, greater DAT levels are directly associated with lower DA turnover and lower changes in synaptic DA concentration. This implies that an important functional role of DAT is to maintain relatively constant synaptic DA levels and to preserve DA in nerve terminals. A decrease in DAT, although potentially serving as a compensatory mechanism in early disease, may ultimately result in increased DA turnover and higher oscillations in synaptic DA concentration, thereby possibly predisposing toward the occurrence of motor complications as disease progresses. Ann Neurol 2007.

PMID: 17886297 [PubMed - as supplied by publisher]

Related LinksAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications. [Brain. 2006][11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. [Brain. 2003]Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies. [Mov Disord. 2006]Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study. [Neurology. 2006]Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. [Brain. 2004]See all Related Articles...
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices.

~ Jean-Martin Charcot


The future is already here — it's just not very evenly distributed. William Gibson
olsen is offline   Reply With QuoteReply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
dopamine info harley Parkinson's Disease 0 09-24-2007 01:13 PM
Loss Of Two Types Of Neurons Triggers Parkinson's (norepinephrine and dopamine) olsen Parkinson's Disease 0 08-15-2007 08:14 AM
Degenerative Changes That Mimic Parkinson's Linked To Reduced Dopamine Storage Stitcher Parkinson's Disease 0 07-26-2007 03:05 PM
What is Dopamine? lou_lou Parkinson's Disease 1 07-04-2007 11:21 PM
Implanting Dopamine Generators In Brain Cells/Improvement In Parkinson's In Monkeys Stitcher Parkinson's Disease 1 05-17-2007 03:22 AM


All times are GMT -5. The time now is 08:56 AM.

Powered by vBulletin • Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.
Search Engine Optimisation provided by DragonByte SEO v2.0.31 (Lite) - vBulletin Mods & Addons Copyright © 2020 DragonByte Technologies Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2020 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.